Detalhe da pesquisa
1.
Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
Hepatol Res
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517681
2.
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Hepatol Res
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300669
3.
Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.
Hepatol Res
; 53(9): 815-828, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243512
4.
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.
Hepatol Res
; 52(5): 449-461, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113468
5.
Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan.
Hepatol Res
; 52(5): 417-421, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35591813
6.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(3): 329-338, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777965
7.
A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.
Hepatology
; 70(2): 621-629, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194739
8.
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.
Hepatol Res
; 50(12): 1355-1364, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886950
9.
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.
Hepatol Res
; 50(11): 1264-1274, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833292
10.
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.
Hepatol Res
; 50(4): 512-523, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837277
11.
Deteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan.
Hepatol Res
; 49(8): 844-852, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957325
12.
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.
Hepatol Res
; 49(9): 1083-1087, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924272
13.
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
Hepatol Res
; 48(3): E372-E378, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872737
14.
Proposed diagnostic criteria for acute-on-chronic liver failure in Japan.
Hepatol Res
; 48(4): 219-224, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361652
15.
A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan.
Hepatol Res
; 48(4): 303-312, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341357
16.
Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-ß injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.
Hepatol Res
; 48(4): 233-243, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884930
17.
[Current status of acute liver failure in Japan].
Nihon Shokakibyo Gakkai Zasshi
; 120(5): 369-378, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37183029
18.
"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Hepatol Res
; 47(13): 1397-1407, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239934
19.
[Current status of acute-on-chronic liver failure in patients with alcoholic liver cirrhosis in Japan].
Nihon Shokakibyo Gakkai Zasshi
; 119(1): 30-38, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35022368
20.
Revised criteria for classification of the etiologies of acute liver failure and late-onset hepatic failure in Japan: A report by the Intractable Hepato-biliary Diseases Study Group of Japan in 2015.
Hepatol Res
; 46(5): 369-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26615003